SEARCH

SEARCH BY CITATION

References

  • Anolik, J.H. , Campbell, D. , Felgar, R.E. , Young, F. , Sanz, I. , Rosenblatt, J. & Looney, R.J. (2003) The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis and Rheumatism, 48, 455459.
  • Bouaziz, J.D. , Yanaba, K. , Venturi, G.M. , Wang, Y. , Tisch, R.M. , Poe, J.C. & Tedder, T.F. (2007) Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proceedings of the National Academy of Sciences of the United States of America, 104, 2087820883.
  • Cambridge, G. , Leandro, M.J. , Teodorescu, M. , Manson, J. , Rahman, A. , Isenberg, D.A. & Edwards, J.C. (2006) B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis and Rheumatism, 54, 36123622.
  • Chow, L. , Aslam, R. , Speck, E.R. , Kim, M. , Cridland, N. , Webster, M.L. , Chen, P. , Sahib, K. , Ni, H. , Lazarus, A.H. , Garvey, M.B. , Freedman, J. & Semple, J.W. (2010) A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy. Blood, 115, 12471253.
  • Cines, D.B. , Bussel, J.B. , Liebman, H.A. & Luning Prak, E.T. (2009) The ITP syndrome: pathogenic and clinical diversity. Blood, 113, 65116521.
  • Cooper, N. , Stasi, R. , Cunningham-Rundles, S. , Feuerstein, M.A. , Leonard, J.P. , Amadori, S. & Bussel, J.B. (2004) The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. British Journal of Haematology, 125, 232239.
  • Davoren, A. , Bussel, J. , Curtis, B.R. , Moghaddam, M. , Aster, R.H. & McFarland, J.G. (2005) Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP). American Journal of Hematology, 78, 193197.
  • Edwards, J.C. , Leandro, M.J. & Cambridge, G. (2005) B lymphocyte depletion in rheumatoid arthritis: targeting of CD20. Current Directions in Autoimmunity, 8, 175192.
  • Ferraro, A.J. , Drayson, M.T. , Savage, C.O. & MacLennan, I.C. (2008) Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. European Journal of Immunology, 38, 292298.
  • Folman, C.C. , von dem Borne, A.E. , Rensink, I.H. , Gerritsen, W. , van der Schoot, C.E. , de Haas, M. & Aarden, L. (1997) Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay. Thrombosis and Haemostasis, 78, 12621267.
  • Harrington, W.J. , Minnich, V. , Hollingsworth, J.W. & Moore, C.V. (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. Journal of Laboratory and Clinical Medicine, 38, 110.
  • Hasan, A. , Michel, M. , Patel, V. , Stasi, R. , Cunningham-Rundles, S. , Leonard, J.P. & Bussel, J. (2009) Repeated courses of rituximab in chronic ITP: three different regimens. American Journal of Hematology, 84, 661665.
  • Koene, H.R. , Kleijer, M. , Algra, J. , Roos, D. , von dem Borne, A.E. & de Haas, M. (1997) Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood, 90, 11091114.
  • Martini, H. , Enright, V. , Perro, M. , Workman, S. , Birmelin, J. , Giorda, E. , Quinti, I. , Lougaris, V. , Baronio, M. , Warnatz, K. & Grimbacher, B. (2011) Importance of B cell co-stimulation in CD4(+) T cell differentiation: X-linked agammaglobulinaemia, a human model. Clinical Experimental Immunology, 164, 381387.
  • Olsson, B. , Andersson, P.O. , Margareta Jernås, M. , Jacobsson, S. , Carlsson, B. , Carlsson, L.M.S. & Wadenvik, H. (2003) T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nature Medicine, 9, 11231124.
  • Olsson, B. , Andersson, P.O. , Jacobsson, S. , Carlsson, L. & Wadenvik, H. (2005) Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thrombosis and Haemostasis, 93, 139144.
  • Patel, V.L. , Schwartz, J. & Bussel, J.B. (2008) The effect of anti-CD40 ligand in immune thrombocytopenic purpura. British Journal of Haematology, 141, 545548.
  • Protheroe, A. , Edwards, J.C. , Simmons, A. , Maclennan, K. & Selby, P. (1999) Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma. Rheumatology (Oxford), 38, 11501152.
  • Semple, J.W. (2002) Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Reviews, 16, 912.
  • Semple, J.W. , Milev, Y. , Cosgrave, D. , Mody, M. , Hornstein, A. , Blanchette, V. & Freedman, J. (1996) Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood, 87, 42454254.
  • Stasi, R. (2010) Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Seminars in hematology, 47, 170179.
  • Stasi, R. , Del Poeta, G. , Stipa, E. , Evangelista, M.L. , Trawinska, M.M. , Cooper, N. & Amadori, S. (2007) Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood, 110, 29242930.
  • Stasi, R. , Cooper, N. , Del Poeta, G. , Stipa, E. , Laura Evangelista, M. , Abruzzese, E. & Amadori, S. (2008) Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood, 112, 11471150.
  • Yu, J. , Heck, S. , Patel, V. , Levan, J. , Yu, Y. , Bussel, J.B. & Yazdanbakhsh, K. (2008) Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood, 112, 13251328.